By proceeding, you agree to our Terms of Use and Privacy Policy.
Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders.
28-30 August 2023
Join us at the Magellan Rx Specialty Summit 2023, a three-day event packed with brilliance, innovation, and networking opportunities. Taking place from August 28th to 30th at the prestigious Sheraton Times Square, this is our highly anticipated 20th
Event Ended
USA
Free
New York City